Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Camurati-Engelmann Syndrome × fresolimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mesothelioma, Malignant 1 Camurati-Engelmann Syndrome 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

fresolimumab 1 bintrafusp alfa protein, human 1 ascrinvacumab 1 Trabedersen 1 Temozolomide 1 Sorafenib 1 Radiotherapy 1 Losartan 1 Lomustine 1 LY-2157299 1 Drug Delivery Systems 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01401062 2019-03-05

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

Weill Medical College of Cornell University

Phase 2 Completed

23 enrolled 8 charts

Breast Neoplasms, Camurati-Engelmann Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡